| HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane SJD Neil, SW Eastman, N Jouvenet, PD Bieniasz PLoS pathogens 2 (5), e39, 2006 | 397 | 2006 |
| HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway J Martin-Serrano, SW Eastman, W Chung, PD Bieniasz The Journal of cell biology 168 (1), 89-101, 2005 | 244 | 2005 |
| Aurora A Kinase Inhibition Is Synthetic Lethal with Loss of the RB1 Tumor Suppressor Gene X Gong, J Du, SH Parsons, FF Merzoug, Y Webster, PW Iversen, LC Chio, ... Cancer discovery 9 (2), 248-263, 2019 | 190 | 2019 |
| A role for ubiquitin ligases and Spartin/SPG20 in lipid droplet turnover SW Eastman, M Yassaee, PD Bieniasz Journal of cell biology 184 (6), 881-894, 2009 | 143 | 2009 |
| Identification of human VPS37C, a component of endosomal sorting complex required for transport-I important for viral budding SW Eastman, J Martin-Serrano, W Chung, T Zang, PD Bieniasz Journal of Biological Chemistry 280 (1), 628-636, 2005 | 120 | 2005 |
| Identification of a conserved residue of foamy virus Gag required for intracellular capsid assembly SW Eastman, ML Linial Journal of Virology 75 (15), 6857-6864, 2001 | 84 | 2001 |
| Foamy virus capsid assembly occurs at a pericentriolar region through a cytoplasmic targeting/retention signal in Gag SF Yu, SW Eastman, ML Linial Traffic 7 (8), 966-977, 2006 | 74 | 2006 |
| Prototype foamy virus envelope glycoprotein leader peptide processing is mediated by a furin-like cellular protease, but cleavage is not essential for viral infectivity A Duda, A Stange, D Lüftenegger, N Stanke, D Westphal, ... Journal of virology 78 (24), 13865-13870, 2004 | 68 | 2004 |
| Particle assembly and genome packaging ML Linial, SW Eastman Foamy Viruses, 89-110, 2003 | 56 | 2003 |
| Molecular basis for necitumumab inhibition of EGFR variants associated with acquired cetuximab resistance A Bagchi, JN Haidar, SW Eastman, M Vieth, M Topper, MD Iacolina, ... Molecular cancer therapeutics 17 (2), 521-531, 2018 | 48 | 2018 |
| Inhibition of p53-mediated growth arrest by overexpression of cyclin-dependent kinases KM Latham, SW Eastman, A Wong, PW Hinds Molecular and cellular biology, 1996 | 45 | 1996 |
| Bispecific targeting of PD-1 and PD-L1 enhances T-cell activation and antitumor immunity H Kotanides, Y Li, M Malabunga, C Carpenito, SW Eastman, Y Shen, ... Cancer Immunology Research 8 (10), 1300-1310, 2020 | 43 | 2020 |
| Mutations in the amino terminus of foamy virus Gag disrupt morphology and infectivity but do not target assembly RB Life, EG Lee, SW Eastman, ML Linial Journal of virology 82 (13), 6109-6119, 2008 | 30 | 2008 |
| Differentiation between the EGFR antibodies necitumumab, cetuximab, and panitumumab: Antibody internalization and EGFR degradation. MB Topper, JR Tonra, B Pytowski, SW Eastman Journal of Clinical Oncology 29 (15_suppl), e13022-e13022, 2011 | 20 | 2011 |
| A bi-functional antibody-receptor domain fusion protein simultaneously targeting IGF-IR and VEGF for degradation Y Shen, L Zeng, R Novosyadlyy, A Forest, A Zhu, A Korytko, H Zhang, ... MAbs 7 (5), 931-945, 2015 | 19 | 2015 |
| LY3076226, a novel anti-FGFR3 antibody drug conjugate exhibits potent and durable anti-tumor activity in tumor models harboring FGFR3 mutations or fusions D Surguladze, A Pennello, X Ren, T Mack, A Rigby, P Balderes, ... Cancer Research 79 (13_Supplement), 4835-4835, 2019 | 13 | 2019 |
| T cells use distinct topographical and membrane receptor scanning strategies that individually coalesce during receptor recognition E Cai, C Beppler, J Eichorst, K Marchuk, SW Eastman, MF Krummel Proceedings of the National Academy of Sciences 119 (32), e2203247119, 2022 | 6 | 2022 |
| Cell cycle control and differentiation: mechanisms of proliferative dysfunction in cancer cells K Latham, GL Baker, K Musunuru, YL Chen, SW Eastman, A Wong Cancer Detect Prev 20 (5), 1996 | 3 | 1996 |
| Compounds to fibroblast growth factor receptor-3 (FGFR3) and methods of treatment PJ Balderes, SW Eastman, HK Erickson, DL Ludwig, CM Moxham, ... US Patent 9,375,488, 2016 | 2 | 2016 |
| Abstract C54: In vitro and in vivo anti-tumor activity of the antimacrophage stimulating 1-receptor antibody IMC-RON8 in breast and bladder cancer models. N Loizos, T Bailey, M Topper, S Eastman, A Pennello, J O'Toole Molecular Cancer Therapeutics 10 (11_Supplement), C54-C54, 2011 | 1 | 2011 |
